ofloxacin has been researched along with cefaclor anhydrous in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Sato, K; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
| Houben, AW; Philips, JH; Stobberingh, EE | 1 |
| Broggio, R; Guerra, L; Xerri, L | 1 |
| Fujita, K; Horie, N; Katsumata, M; Kukita, A; Nakano, M; Nonami, E; Shishiba, T; Someya, T; Watanabe, R; Watanabe, S | 1 |
| Fujimori, I; Hiraga, Y; Kikuchi, K; Kobayashi, Y; Nakayama, I; Obana, M; Saito, A; Takebe, K; Tomizawa, M; Yamamoto, A | 1 |
| Ikeda, N | 1 |
| Belousov, IuB; Efremenkova, OV; Komarova, VP; Sokolov, AV; Tishchenkova, IF | 1 |
| Aoki, K; Hayashi, M; Kawano, Y; Noma, T; Shikishima, Y; Yoshizawa, I | 1 |
| Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Furudoi, S; Komori, T; Ohtsuka, Y; Yoshii, T; Yoshikawa, T; Yoshioka, A | 1 |
| Furugo, I; Ishida, M; Takii, M; Ueda, M | 1 |
| Good, CE; Jakielaszek, C; Koeth, LM; Saunders, KA | 1 |
1 review(s) available for ofloxacin and cefaclor anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for ofloxacin and cefaclor anhydrous
| Article | Year |
|---|---|
[Comparative clinical study of DL-8280 and cefaclor for suppurative skin and soft tissue infections by a double-blind method].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Skin Diseases, Infectious; Suppuration | 1984 |
[Comparative clinical study of ofloxacin and cefaclor in bacterial bronchitis].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines | 1984 |
15 other study(ies) available for ofloxacin and cefaclor anhydrous
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Antibacterial activity of ciprofloxacin against fresh clinical isolates from superficial suppurative foci].
Topics: Amoxicillin; Bacteria; Cefaclor; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Suppuration | 1991 |
In vitro activity of cefpodoxime, a new oral cephalosporin.
Topics: beta-Lactamases; Cefaclor; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas | 1989 |
Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefaclor; Escherichia coli; Humans; Kinetics; Ofloxacin; Oxazines; Proteus; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus | 1986 |
[Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae from clinical specimens].
Topics: Cefaclor; Drug Resistance, Microbial; Erythromycin; Humans; Ofloxacin; Oxacillin; Penicillin Resistance; Serotyping; Streptococcus pneumoniae | 1995 |
[Treatment of lower respiratory tract infections in the elderly].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Ciprofloxacin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillins | 1997 |
A comparative investigation of the restorative effects of roxithromycin on neutrophil activities.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Blood Bactericidal Activity; Cefaclor; Cephalosporins; Child; Disabled Persons; Drug Interactions; Female; Flow Cytometry; Humans; Hydrogen Peroxide; Macrophage-1 Antigen; Male; Monobactams; Neutrophils; Ofloxacin; Phagocytosis; Roxithromycin | 1998 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Topics: Ampicillin; Anti-Infective Agents; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Evaluation of oral antimicrobial agent levels in tooth extraction sites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Process; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefmenoxime; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Prodrugs; Staphylococcal Infections; Streptococcus; Talampicillin; Time Factors; Tooth Diseases; Tooth Extraction; Tooth Socket | 2001 |
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins | 2002 |
Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefaclor; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 2004 |